Can Oral Polio Vaccination Help Prevent COVID-19?

California based Biomed Industries, Inc. announced on September 4, 2020, the initiation of a Phase 3 study with 3,600 participants to evaluate the efficacy and safety of oral polio vaccine and NA-831™ for prophylaxis and treatment of early onset of COVID-19.

Both poliovirus and coronavirus are positive-strand RNA viruses and they may induce and be affected by common innate immunity mechanisms. Recent reports indicate that COVID-19 may result in suppressed innate immune responses.

"We believe that a drug combination of NA-831™ with an oral polio vaccine could offer a safe, efficacious, and low-cost prevention and treatment for COVID-19," stated Lloyd L. Tran, CEO of Biomed.